The nature of conflict in community pharmacy - A pilot study of pharmacists' experiences during the COVID-19 pandemic


Posted: 2021-09-15 19:00:00
Background: The COVID-19 pandemic has caused changes that disrupted the status quo of society. As a result, the level of conflict in community pharmacy has increased significantly. With existing conflict research more focused on the management of conflict, it is important to direct attention towards understanding the nature of conflict. This understanding will allow for informed resources to be developed to guide practice, decreasing the occurrence of and negative effects of conflict. Objective: This research explored experiences of pharmacists working in community pharmacies, to identify the occurrence and nature of conflicts which may have been motivated by changes resulting directly or indirectly from the COVID-19 pandemic, to provide directions for future research into the nature of conflict. Method: Person-to-person semi-structured telephone interviews were conducted. Transcripts were analysed using inductive reasoning to identify themes. Results: Thirteen pharmacists agreed to participate in this study and 9 were interviewed. Analysis revealed 7 themes that described the causes, contributors, management, outcome, and essence of experienced conflict. A model that incorporated existing theory and themes derived from this study was developed to facilitate understanding of the nature of conflict in community pharmacy during the COVID-19 pandemic. Conclusion: Conflict in community pharmacy settings follows a defined model with multiple interrelated themes. Guidance from this model may assist pharmacists in reducing occurrences of dysfunctional conflicts during their practice. Keywords: COVID-19; Community pharmacy; Conflict; Conflict management; Coronavirus; Pharmacy practice.

参考サイト PubMed: covid-19


Powered by Vergleichsportal


バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
9月 28, 2020 バイオアソシエイツ

Johnson&Johnsonは6万人の被験者を対象としたCOVID-19ワクチン候補のフェーズ3有効性試験を開始

COVID-19 のほとんどの人は比較的軽度の症状だが、一部の人は重度の肺炎と呼吸不全を発症し、死に至る可能性がある。Beth Israel Deaconess Medical Center(BIDMC)の免疫学者Dan H. Barouch医学博士らは、最近発表されたこれまでの研究で、COVID-19ワクチン候補が中和抗体を産生し、COVID-19を引き起こすウイルスSARS-CoV-2から非ヒト霊長類(NHP)を強力に保護することを示した。2020年9月3日にNature…